Till startsida
Sitemap
To content Read more about how we use cookies on gu.se

Charlotte Andersson

Doctoral student

Charlotte Andersson
Doctoral student
charlotte.andersson@gu.se

Postal Address: Sahlgrenska universitetssjukhuset, 41345 Göteborg
Visiting Address: Gula stråket 2 b su/sahlgrenska , 41345 Göteborg


Department of Radiation Physics at Institute of Clinical Sciences (More Information)
Sahlgrenska Universitetssjukhuset
413 45 Göteborg
Visiting Address: Gula stråket 2 B SU/Sahlgrenska , 413 45 Göteborg

Latest publications

rA1M, a kidney protector during PRRT?
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
European Radiation Protection Week, Stockholm, Sweden, 2019, 14-18 October, Conference contribution 2019
Conference contribution

Chronotherapy: a possible way to optimze 131I-based therapy?
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
European Radiation Protection Week, Stockholm, Sweden, 2019, 14-18 October, Conference contribution 2019
Conference contribution

The protective antioxidant rA1M allows full antitumor effects of 177Luoctreotate treatment in PDX neuroendocrine tumor models
Charlotte Andersson, Emman Shubbar, Emil Schüler, Bo Åkerström, Magnus Gram et al.
Gothenburg Cancer meeting, Gothenburg, Sweden, 2019, May 6-7, Conference contribution 2019
Conference contribution

Co-administration of rA1M during 177Lu-octreotate treatment does not interfere with the therapeutic effect
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The North American Neuroendocrine Tumor Society, Seattle, 2018, Oktober 4-6, Conference contribution 2018
Conference contribution

Potential protection of renal function in 177Lu-octreotate treatment using alpha-1-microglobulin
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The European Association of Nuclear Medicine , Düsseldorf, 2018, Oktober 13-17, Conference contribution 2018
Conference contribution

Kidney protection during treatment with 177Lu-octreotate using recombinant alpha-1-microglobulin
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The Swedish Radiation Research Association for young Scientists Workshop , Uppsala, 2018, Augusti 29-31, Conference contribution 2018
Conference contribution

A1M is a potential kidney protector in 177Lu-octreotate treatment of neuroendocrine tumours
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
2nd European Congress of Medical Physics, Köpenhamn, 2018, Augusti 23-25, Conference contribution 2018
Conference contribution

Sex-dependent absorbed doses from 131I in male and female mice
Mikael Elvborn, Charlotte Andersson, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

Circadian rhythm: a factor influencing biodistribution of 131I in mice
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

Showing 1 - 10 of 15

2019

rA1M, a kidney protector during PRRT?
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
European Radiation Protection Week, Stockholm, Sweden, 2019, 14-18 October, Conference contribution 2019
Conference contribution

Chronotherapy: a possible way to optimze 131I-based therapy?
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
European Radiation Protection Week, Stockholm, Sweden, 2019, 14-18 October, Conference contribution 2019
Conference contribution

The protective antioxidant rA1M allows full antitumor effects of 177Luoctreotate treatment in PDX neuroendocrine tumor models
Charlotte Andersson, Emman Shubbar, Emil Schüler, Bo Åkerström, Magnus Gram et al.
Gothenburg Cancer meeting, Gothenburg, Sweden, 2019, May 6-7, Conference contribution 2019
Conference contribution

2018

Co-administration of rA1M during 177Lu-octreotate treatment does not interfere with the therapeutic effect
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The North American Neuroendocrine Tumor Society, Seattle, 2018, Oktober 4-6, Conference contribution 2018
Conference contribution

Potential protection of renal function in 177Lu-octreotate treatment using alpha-1-microglobulin
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The European Association of Nuclear Medicine , Düsseldorf, 2018, Oktober 13-17, Conference contribution 2018
Conference contribution

Kidney protection during treatment with 177Lu-octreotate using recombinant alpha-1-microglobulin
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
The Swedish Radiation Research Association for young Scientists Workshop , Uppsala, 2018, Augusti 29-31, Conference contribution 2018
Conference contribution

A1M is a potential kidney protector in 177Lu-octreotate treatment of neuroendocrine tumours
Charlotte Andersson, Emman Shubbar, Bo Åkerström, Magnus Gram, Eva Forssell-Aronsson
2nd European Congress of Medical Physics, Köpenhamn, 2018, Augusti 23-25, Conference contribution 2018
Conference contribution

2017

Sex-dependent absorbed doses from 131I in male and female mice
Mikael Elvborn, Charlotte Andersson, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

Circadian rhythm: a factor influencing biodistribution of 131I in mice
Charlotte Andersson, Mikael Elvborn, Johan Spetz, Britta Langen, Eva Forssell-Aronsson
63rd Annual Meeting of the Radiation Research Society, Cancun, Mexico, Conference contribution 2017
Conference contribution

Showing 1 - 10 of 15

Page Manager: Johan Spetz|Last update: 11/20/2013
Share:

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?